In the blood samples of CLL patients, we detected increased BCL2 levels in both CD5+CD19+ cells, typical for CLL, and in the CD19+ positive single cells (Figure 4). This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.